Hellen Ishikawa-Ankerhold

Dr. Hellen Ishikawa-Ankerhold

Walter Brendel Centre of Experimental Medicine, Department of Cardiology, Ludwig Maximilian University of Munich, Marchioninistraße 27, D-81377 München, Germany
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2012 in Molecules
Verified
Journal Article
Open access
PDF file
HIHellen Ishikawa-Ankerhold
Hellen Ishikawa-Ankerhold
RARichard Ankerhold
Richard Ankerhold
Gregor DrummenGregor Drummen
Gregor Drummen
Fluorescence microscopy provides an efficient and unique approach to study fixed and living cells because of its versatility, specificity, and high sensitivity. Fluorescence microscopes can both detect the fluorescence emitted from labeled molecules in biological samples as images or photometric data from which intensities and emission spectra can be deduced. By exploiting the characteristics of fluorescence, various techniques have been developed that enable the visualization and analysis of complex dynamic events in cells, organelles, and sub-organelle components within the biological specimen. The techniques described here are fluorescence recovery after photobleaching (FRAP), the related fluorescence loss in photobleaching (FLIP), fluorescence localization after photobleaching (FLAP), Förster or fluorescence resonance energy transfer (FRET) and the different ways how to measure FRET, such as acceptor bleaching, sensitized emission, polarization anisotropy, and fluorescence lifetime imaging microscopy (FLIM). First, a brief introduction into the mechanisms underlying fluorescence as a physical phenomenon and fluorescence, confocal, and multiphoton microscopy is given. Subsequently, these advanced microscopy techniques are introduced in more detail, with a description of how these techniques are performed, what needs to be considered, and what practical advantages they can bring to cell biological research.

1 November 2017 in Cell
Verified
Journal Article
Closed access
FGFlorian Gaertner
Florian Gaertner
ZAZerkah Ahmad
Zerkah Ahmad
GRGerhild Rosenberger
Gerhild Rosenberger
SFShuxia Fan
Shuxia Fan
LNLeo Nicolai
Leo Nicolai
SMSteffen Massberg
Steffen Massberg

8 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
CSChristopher Stremmel
Christopher Stremmel
RSR. Schuchert
R. Schuchert
FWF. Wagner
F. Wagner
RTR. Thaler
R. Thaler
TWT. Weinberger
T. Weinberger
CSChristian Schulz
Christian Schulz
Tissue macrophages in many adult organs originate from yolk sac (YS) progenitors, which invade the developing embryo and persist by means of local self-renewal. However, the route and characteristics of YS macrophage trafficking during embryogenesis are incompletely understood. Here we show the early migration dynamics of YS-derived macrophage progenitors in vivo using fate mapping and intravital microscopy. From embryonic day 8.5 (E8.5) CX3CR1+ pre-macrophages are present in the mouse YS where they rapidly proliferate and gain access to the bloodstream to migrate towards the embryo. Trafficking of pre-macrophages and their progenitors from the YS to tissues peaks around E10.5, dramatically decreases towards E12.5 and is no longer evident from E14.5 onwards. Thus, YS progenitors use the vascular system during a restricted time window of embryogenesis to invade the growing fetus. These findings close an important gap in our understanding of the development of the innate immune system.

1 April 2009 in Biophysical Journal
Verified
Journal Article
Closed access
TBTill Bretschneider
Till Bretschneider
KAKurt Anderson
Kurt Anderson
MEMary Ecke
Mary Ecke
Annette Müller-TaubenbergerAnnette Müller-Taubenberger
Annette Müller-Taubenberger
BSBritta Schroth-Diez
Britta Schroth-Diez
GGGünther Gerisch
Günther Gerisch

18 April 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JPJoachim Pircher
Joachim Pircher
TCThomas Czermak
Thomas Czermak
AEAndreas Ehrlich
Andreas Ehrlich
CEClemens Eberle
Clemens Eberle
EGErik Gaitzsch
Erik Gaitzsch
CSChristian Schulz
Christian Schulz
Leukocyte-released antimicrobial peptides contribute to pathogen elimination and activation of the immune system. Their role in thrombosis is incompletely understood. Here we show that the cathelicidin LL-37 is abundant in thrombi from patients with acute myocardial infarction. Its mouse homologue, CRAMP, is present in mouse arterial thrombi following vascular injury, and derives mainly from circulating neutrophils. Absence of hematopoietic CRAMP in bone marrow chimeric mice reduces platelet recruitment and thrombus formation. Both LL-37 and CRAMP induce platelet activation in vitro by involving glycoprotein VI receptor with downstream signaling through protein tyrosine kinases Src/Syk and phospholipase C. In addition to acute thrombosis, LL-37/CRAMP-dependent platelet activation fosters platelet–neutrophil interactions in other inflammatory conditions by modulating the recruitment and extravasation of neutrophils into tissues. Absence of CRAMP abrogates acid-induced lung injury, a mouse pneumonia model that is dependent on platelet–neutrophil interactions. We suggest that LL-37/CRAMP represents an important mediator of platelet activation and thrombo-inflammation.

21 October 2022 in Immunity
Verified
Journal Article
Open access
TPTobias Petzold
Tobias Petzold
ZZZhe Zhang
Zhe Zhang
IBIván Ballesteros
Iván Ballesteros
ISInas Saleh
Inas Saleh
APAmin Polzin
Amin Polzin
SMSteffen Massberg
Steffen Massberg
Intravascular neutrophils and platelets collaborate in maintaining host integrity, but their interaction can also trigger thrombotic complications. We report here that cooperation between neutrophil and platelet lineages extends to the earliest stages of platelet formation by megakaryocytes in the bone marrow. Using intravital microscopy, we show that neutrophils “plucked” intravascular megakaryocyte extensions, termed proplatelets, to control platelet production. Following CXCR4-CXCL12-dependent migration towards perisinusoidal megakaryocytes, plucking neutrophils actively pulled on proplatelets and triggered myosin light chain and extracellular-signal-regulated kinase activation through reactive oxygen species. By these mechanisms, neutrophils accelerate proplatelet growth and facilitate continuous release of platelets in steady state. Following myocardial infarction, plucking neutrophils drove excessive release of young, reticulated platelets and boosted the risk of recurrent ischemia. Ablation of neutrophil plucking normalized thrombopoiesis and reduced recurrent thrombosis after myocardial infarction and thrombus burden in venous thrombosis. We establish neutrophil plucking as a target to reduce thromboischemic events.